VPREB1: Difference between revisions
CSV import |
No edit summary |
||
| Line 11: | Line 11: | ||
== Research == | == Research == | ||
Research into the VPREB1 gene and its associated protein continues to be a significant area of interest in the field of [[immunology]]. Understanding the role of this gene in B-cell development and immune response could lead to new treatments for immune disorders and cancers. | Research into the VPREB1 gene and its associated protein continues to be a significant area of interest in the field of [[immunology]]. Understanding the role of this gene in B-cell development and immune response could lead to new treatments for immune disorders and cancers. | ||
== See Also == | == See Also == | ||
| Line 20: | Line 18: | ||
* [[Leukemia]] | * [[Leukemia]] | ||
* [[Lymphoma]] | * [[Lymphoma]] | ||
[[Category:Genes]] | [[Category:Genes]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Medical genetics]] | [[Category:Medical genetics]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 16:15, 19 November 2024
VPREB1 is a gene that encodes the pre-B lymphocyte protein 1 in humans. This protein is a component of the surrogate light chain (SLC), which is crucial for early B-cell development.
Function[edit]
VPREB1 is a part of the immunoglobulin superfamily and is expressed in early and late pre-B lymphocytes. It forms a complex with another protein, lambda 5, to form the surrogate light chain. This complex is involved in the early stages of B-cell development, specifically in the pre-B-cell receptor (pre-BCR) stage. The pre-BCR is a precursor to the B-cell receptor (BCR), which is essential for B-cell activation and immune response.
Clinical Significance[edit]
Mutations in the VPREB1 gene have been associated with various immune disorders. For instance, a decrease in VPREB1 expression has been observed in patients with common variable immunodeficiency (CVID), a disorder characterized by low levels of most or all of the immunoglobulin classes.
Furthermore, VPREB1 has been implicated in certain types of cancer, such as leukemia and lymphoma. In these cases, the VPREB1 gene is often found to be overexpressed, leading to an increase in early B-cell development and potentially contributing to the proliferation of cancerous cells.
Research[edit]
Research into the VPREB1 gene and its associated protein continues to be a significant area of interest in the field of immunology. Understanding the role of this gene in B-cell development and immune response could lead to new treatments for immune disorders and cancers.
See Also[edit]
